SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(van der Schaaf Rene J)
 

Sökning: WFRF:(van der Schaaf Rene J) > Bioresorbable Scaff...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004407naa a2200481 4500
001oai:DiVA.org:uu-342873
003SwePub
008180223s2017 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3428732 URI
024a https://doi.org/10.1056/NEJMoa16149542 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Wykrzykowska, Joanna J4 aut
2451 0a Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
264 1c 2017
338 a print2 rdacarrier
500 a Collaborator Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
520 a BACKGROUND: Bioresorbable vascular scaffolds were developed to overcome the shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We performed an investigator-initiated, randomized trial to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in the context of routine clinical practice.METHODS: We randomly assigned 1845 patients undergoing PCI to receive either a bioresorbable vascular scaffold (924 patients) or a metallic stent (921 patients). The primary end point was target-vessel failure (a composite of cardiac death, target-vessel myocardial infarction, or target-vessel revascularization). The data and safety monitoring board recommended early reporting of the study results because of safety concerns. This report provides descriptive information on end-point events.RESULTS: The median follow-up was 707 days. Target-vessel failure occurred in 105 patients in the scaffold group and in 94 patients in the stent group (2-year cumulative event rates, 11.7% and 10.7%, respectively; hazard ratio, 1.12; 95% confidence interval [CI], 0.85 to 1.48; P=0.43); event rates were based on Kaplan-Meier estimates in time-to-event analyses. Cardiac death occurred in 18 patients in the scaffold group and in 23 patients in the stent group (2-year cumulative event rates, 2.0% and 2.7%, respectively), target-vessel myocardial infarction occurred in 48 patients in the scaffold group and in 30 patients in the stent group (2-year cumulative event rates, 5.5% and 3.2%), and target-vessel revascularization occurred in 76 patients in the scaffold group and in 65 patients in the stent group (2-year cumulative event rates, 8.7% and 7.5%). Definite or probable device thrombosis occurred in 31 patients in the scaffold group as compared with 8 patients in the stent group (2-year cumulative event rates, 3.5% vs. 0.9%; hazard ratio, 3.87; 95% CI, 1.78 to 8.42; P<0.001).CONCLUSIONS: In this preliminary report of a trial involving patients undergoing PCI, there was no significant difference in the rate of target-vessel failure between the patients who received a bioresorbable scaffold and the patients who received a metallic stent. The bioresorbable scaffold was associated with a higher incidence of device thrombosis than the metallic stent through 2 years of follow-up. (Funded by Abbott Vascular; AIDA ClinicalTrials.gov number, NCT01858077 .).
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Kraak, Robin P4 aut
700a Hofma, Sjoerd H4 aut
700a van der Schaaf, Rene J4 aut
700a Arkenbout, E Karin4 aut
700a IJsselmuiden, Alexander J4 aut
700a Elias, Joëlle4 aut
700a van Dongen, Ivo M4 aut
700a Tijssen, Ruben Y G4 aut
700a Koch, Karel T4 aut
700a Baan, Jan4 aut
700a Vis, M Marije4 aut
700a de Winter, Robbert J4 aut
700a Piek, Jan J4 aut
700a Tijssen, Jan G P4 aut
700a Henriques, Jose P S4 aut
700a James, Stefanu Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala kliniska forskningscentrum (UCR)0 (Swepub:uu)stjam367
710a Uppsala universitetb Institutionen för medicinska vetenskaper4 org
773t New England Journal of Medicineg 376:24, s. 2319-2328q 376:24<2319-2328x 0028-4793x 1533-4406
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-342873
8564 8u https://doi.org/10.1056/NEJMoa1614954

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy